Melanie Senior

20 Years of Experience

About

Melanie is a reporter, commentator, and industry analyst within the biopharmaceutical and medtech industry. Melanie is a specialist within consulting across market access, pricing, outcomes-based care, precision medicine, digital health, AI, R&D strategies and consumer empowerment for a range of clients in biopharma and investment community. Her expertise is valued at Wharton Business School's Pharmaceutical Executive course training in the area of pricing and market access modules.

She is a speaker and presenter for corporate development and strategist teams and moderator at key industry events.

Melanie is a graduate of the University Of Cambridge with a Bachelor’s degree in Natural Science and has earned her Master degree from the University of Sheffield in International Health Technology Assessment, Pricing, and Reimbursement

Specialties
Publications
Articles from Melanie Senior:
Read all from this author
Business Strategies

Devices for Depression: Can Magnetism become Mainstream?

  • 2014-11-25 00:00:00.0
  • Melanie Senior
  • MedTech Strategist

Transcranial magnetic stimulation is slowly making inroads for the treatment of depression, but TMS has yet to hit the big-time. Payors balk at uncertain proof of efficacy and high up-front costs, while psychiatrists are trained to work with pharmaco- and behavioral therapy, not devices. As the current generation of TMS players struggles to raise awareness and change the depression treatment paradigm, a new generation of TMS systems is emerging that could be more effective.

Read Article